Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104557851B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104557851B reveals a novel catalytic route for Eliglustat intermediates. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical partners.